Kirkland & Ellis advised health care investment firm Altaris, LLC on the acquisition of digital health company Sharecare, Inc. (Nasdaq: SHCR). The transaction was announced June 21, 2024. Under the terms of the merger agreement, Sharecare stockholders will receive $1.43 in cash per share, which represents a premium of approximately 85% over the closing price of Sharecare on June 20, 2024. The implied equity value is approximately $540 million. The transaction is expected to close in the second half of 2024, subject to customary closing conditions, including approval by Sharecare stockholders and the receipt of required regulatory approvals. Read the transaction press release The Kirkland team was led by corporate partners David Feirstein and William Lay; tax partner Sara Zablotney; capital markets partner Josh Korff; and executive compensation partner Scott Price.